FTRP
NASDAQField Trip Health Ltd.
Field Trip Health Ltd. (FTRP) is a public company listed on NASDAQ. There were no new wire items for FTRP in the last 30 days. The most recent was published Jan 9, 2023.
Latest news
25 items- SECSEC Form 6-K filed by Field Trip Health Ltd.6-K - Reunion Neuroscience Inc. (0001865482) (Filer)
- SECSEC Form 6-K filed by Field Trip Health Ltd.6-K - Reunion Neuroscience Inc. (0001865482) (Filer)
- SECSEC Form 6-K filed by Field Trip Health Ltd.6-K - Reunion Neuroscience Inc. (0001865482) (Filer)
- SECSEC Form S-8 filed by Field Trip Health Ltd.S-8 - Reunion Neuroscience Inc. (0001865482) (Filer)
- SECSEC Form 6-K filed by Field Trip Health Ltd.6-K - Reunion Neuroscience Inc. (0001865482) (Filer)
- SECSEC Form SUPPL filed by Field Trip Health Ltd.SUPPL - Reunion Neuroscience Inc. (0001865482) (Filer)
- SECSEC Form 6-K filed by Field Trip Health Ltd.6-K - Reunion Neuroscience Inc. (0001865482) (Filer)
- SECSEC Form 6-K filed by Field Trip Health Ltd.6-K - Reunion Neuroscience Inc. (0001865482) (Filer)
- SECSEC Form 6-K filed by Field Trip Health Ltd.6-K - Reunion Neuroscience Inc. (0001865482) (Filer)
- NEWS4 Psychedelics Companies Post Financial Results: Learn How Field Trip, Wesana, Braxia and Irwin Naturals PerformedField Trip (NASDAQ:FTRP), Wesana (OTCQB:WSNAF), Braxia (OTC:BRAXF) and Irwin Naturals (OTC: IWINF) released their quarterly results. Field Trip Health & Wellness Ltd. Psychedelic-assisted therapy provider Field Trip (TSXV:FTHW) reported its fiscal and business results for the three-month period ended June 30, 2022. The company recently split into two new public companies to separate drug development on one hand, and healthcare and wellness on the other: Field Trip Discovery and Field Trip Health, which are now called Reunion Neuroscience Inc. and Field Trip Health & Wellness (or Field Trip alone). The latter’s financial results for the three months ended June 30, 2022 are the following
- NEWSPsychedelic Stock Gainers And Losers From August 16, 2022GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 4.17% at $0.35 Cybin (AMEX:CYBN) shares closed up 1.94% at $0.77 ATAI Life Sciences (NASDAQ:ATAI) shares closed up 1.92% at $4.77 Field Trip Health (NASDAQ:FTRP) shares closed up 1.07% at $0.84 LOSERS: GH Research (NASDAQ:GHRS) shares closed down 9.37% at $12.09 Allied (OTC:ALID) shares closed down 8.33% at $0.44 Seelos Therapeutics (NASDAQ:SEEL) shares closed down 5.28% at $0.92 Numinus Wellness (OTC:NUMIF) shares closed down 2.96% at $0.23 Compass Pathways (NASDAQ:CMPS) shares closed down 2.91% at $17.37 Mind Medicine (NASDAQ:MNMD) shares closed down 2.86% at $0.68 Biomind Labs (OTC:BMNDF) shares closed down 0.00
- PRReunion Neuroscience Inc. to Commence Trading on the Toronto Stock Exchange on August 17, 2022TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (formerly, Field Trip Health Ltd., the "Company" or "Reunion"), a global leader in the discovery and development of innovative of psychedelic-inspired therapeutics for improved mental health outcomes, is pleased to announce that its common shares (the "Shares") will commence trading on the Toronto Stock Exchange ("TSX") under the ticker symbol "REUN" at the opening of the market on August 17, 2022. Trading of the Company's shares on the TSX represents the last step in the corporate reorganization that resulted in the spinout of the Company's former subsidiary, Field Trip Health & Wellness Ltd. ("FTHW") into a stand-alone
- SECSEC Form 6-K filed by Field Trip Health Ltd.6-K - Reunion Neuroscience Inc. (0001865482) (Filer)
- SECSEC Form 6-K filed by Field Trip Health Ltd.6-K - Reunion Neuroscience Inc. (0001865482) (Filer)
- PRReunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal First Quarter 2023 Financial Results, Completed Corporate Reorganization on August 11, 2022Completed corporate reorganization, separating the Field Trip Discovery and Field Trip Health divisions into two separate companies.Field Trip Discovery renamed Reunion Neuroscience Inc. ("Reunion" or the "Company"), and will remain listed on the NASDAQ Stock Market and Toronto Stock Exchange under new ticker symbol "REUN".Field Trip Health renamed Field Trip Health & Wellness Ltd. ("Field Trip H&W") and has received listing approval from the Toronto Stock Exchange Venture under new ticker symbol "FTHW".First day of trading for both Reunion and Field Trip H&W is August 17, 2022.On July 21, 2022, announced successful first dosings in the Company's Phase 1 Clinical Study of its first novel psy
- NEWSAllied, Cybin Among Top Psychedelic Movers Of TodayGAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.70% at $0.98 ATAI Life Sciences (NASDAQ:ATAI) shares closed up 2.18% at $4.68 Revive Therapeutics (OTC:RVVTF) shares closed up 1.82% at $0.34 LOSERS: Allied (OTC:ALID) shares closed down 12.73% at $0.48 Cybin (AMEX:CYBN) shares closed down 6.21% at $0.75 Numinus Wellness (OTC:NUMIF) shares closed down 4.78% at $0.24 Mind Medicine (NASDAQ:MNMD) shares closed down 3.53% at $0.70 Compass Pathways (NASDAQ:CMPS) shares closed down 2.53% at $17.89 Field Trip Health (NASDAQ:FTRP) shares closed down 1.98% at $0.83 Biomind Labs (OTC:BMNDF) shares closed down 0.00% at $0.75 GH Research (NASDAQ:GHRS) shares closed down 0.
- NEWSEarnings Scheduled For August 15, 2022Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. • GreenPower Motor Co (NASDAQ:GP) is estimated to report quarterly loss at $0.15 per share on revenue of $5.59 million. • Mondee Hldgs (NASDAQ:MOND) is likely to report quarterly loss at $0.04 per share on revenue of $38.94 million. • Reshape Lifesciences (NASDAQ:RSLS) is expected to report quarterly loss at $0.35 per share on revenue of $3.41 million. • Alaunos Therapeutics (NASDAQ:TCRT) is expected to report earnings for its second quarter. • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $0.19 per share on revenue of $5.25 million. • IM Cannab
- NEWSMind Medicine, Numinus Wellness Among Top Psychedelic Movers From TodayGAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 11.58% at $0.73 Numinus Wellness (OTC:NUMIF) shares closed up 11.53% at $0.25 Allied (OTC:ALID) shares closed up 7.84% at $0.55 Compass Pathways (NASDAQ:CMPS) shares closed up 5.91% at $18.36 GH Research (NASDAQ:GHRS) shares closed up 5.79% at $13.33 Seelos Therapeutics (NASDAQ:SEEL) shares closed up 4.79% at $0.95 ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.39% at $4.58 Revive Therapeutics (OTC:RVVTF) shares closed up 3.13% at $0.33 LOSERS: Cybin (AMEX:CYBN) shares closed down 6.60% at $0.80 Field Trip Health (NASDAQ:FTRP) shares closed down 0.00% at $0.85 Biomind Labs (OTC:BMNDF) shares closed down 0.00% at $
- NEWSField Trip Announces Closing Of Plan Of Arrangement, $19.9M Private Placement Financing- Field Trip Health Ltd. has been renamed "Reunion Neuroscience Inc." and remains listed on the NASDAQ Stock Market and Toronto Stock Exchange under the ticker symbol "FTRP" with such ticker symbol changing to "REUN" - Field Trip Health & Wellness Ltd. to be listed on the TSX Venture Exchange under ticker symbol “FTHW” - First day of trading for both Reunion and Field Trip Health & Wellness expected to occur on or about August 17, 2022 - Field Trip Health & Wellness Ltd. completes $19.9 million private placement financing
- NEWSCompass Pathways, Revive Therapeutics Among Top Psychedelic Movers Of TodayGAINERS: Allied (OTC:ALID) shares closed up 6.25% at $0.51 GH Research (NASDAQ:GHRS) shares closed up 2.19% at $12.60 Numinus Wellness (OTC:NUMIF) shares closed up 1.68% at $0.22 LOSERS: Compass Pathways (NASDAQ:CMPS) shares closed down 12.16% at $17.33 Revive Therapeutics (OTC:RVVTF) shares closed down 9.86% at $0.32 ATAI Life Sciences (NASDAQ:ATAI) shares closed down 5.34% at $4.43 Seelos Therapeutics (NASDAQ:SEEL) shares closed down 2.53% at $0.91 Mind Medicine (NASDAQ:MNMD) shares closed down 0.21% at $0.65 Biomind Labs (OTC:BMNDF) shares closed down 0.00% at $0.75 Field Trip Health (NASDAQ:FTRP) shares closed down 0.58% at $0.85 Cybin (AMEX:CYBN) shares closed down 0
- PRField Trip Announces Closing of Plan of Arrangement and $19.9 Million Private Placement Financing- Field Trip Health Ltd. has been renamed "Reunion Neuroscience Inc." and remains listed on the NASDAQ Stock Market and Toronto Stock Exchange under the ticker symbol "FTRP" with such ticker symbol changing to "REUN"- Field Trip Health & Wellness Ltd. to be listed on the TSX Venture Exchange under ticker symbol "FTHW" - First day of trading for both Reunion and Field Trip Health & Wellness expected to occur on or about August 17, 2022 - Field Trip Health & Wellness Ltd. completes $19.9 million private placement financing TORONTO, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc., (formerly, Field Trip Health Ltd.) (TSX:FTRP, NASDAQ:FTRP) (the "Company"), and Field Trip Health &
- NEWSPsychedelic Stock Gainers And Losers From August 10, 2022GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 12.32% at $0.65 GH Research (NASDAQ:GHRS) shares closed up 10.02% at $12.74 Cybin (AMEX:CYBN) shares closed up 7.57% at $0.85 ATAI Life Sciences (NASDAQ:ATAI) shares closed up 6.12% at $4.68 Seelos Therapeutics (NASDAQ:SEEL) shares closed up 4.52% at $0.93 Compass Pathways (NASDAQ:CMPS) shares closed up 4.17% at $19.73 Revive Therapeutics (OTC:RVVTF) shares closed up 1.43% at $0.35 Allied (OTC:ALID) shares closed up 1.05% at $0.48 LOSERS: Numinus Wellness (OTC:NUMIF) shares closed down 2.48% at $0.22 Field Trip Health (NASDAQ:FTRP) shares closed down 0.58% at $0.85 Biomind Labs (OTC:BMNDF) shares closed down 0.00% at $
- NEWSCybin, Field Trip Health Among Top Psychedelic Movers Of TodayGAINERS: Cybin (AMEX:CYBN) shares closed up 10.35% at $0.79 Field Trip Health (NASDAQ:FTRP) shares closed up 6.25% at $0.85 Allied (OTC:ALID) shares closed up 1.06% at $0.47 LOSERS: Numinus Wellness (OTC:NUMIF) shares closed down 5.09% at $0.23 Compass Pathways (NASDAQ:CMPS) shares closed down 3.56% at $18.94 GH Research (NASDAQ:GHRS) shares closed down 3.50% at $11.58 Revive Therapeutics (OTC:RVVTF) shares closed down 2.80% at $0.35 Mind Medicine (NASDAQ:MNMD) shares closed down 1.68% at $0.58 Seelos Therapeutics (NASDAQ:SEEL) shares closed down 1.16% at $0.89 ATAI Life Sciences (NASDAQ:ATAI) shares closed down 0.45% at $4.41 Biomind Labs (OTC:BMNDF) shares closed dow
- PRField Trip Health Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 16, 2022, at 8:30 AM ETTORONTO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, NASDAQ:FTRP) ("Field Trip" or the "Company"), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for its fiscal 2023 first quarter for the three-month period ended June 30, 2022, after market close on Monday, August 15, 2022. The Company will conduct a conference call and webcast to discuss its results the following morning, Tuesday, August 16, 2022 at 8:30 a.m. ET. To access the call, please dial 1-877-407-9716 (within the U.S.) or 1-201-493-6779 (outside the U.S.) and provide conference ID 13731900. A live webcast of the conferenc
- NEWSGH Research, Numinus Wellness Among Top Psychedelic Movers Of TodayGAINERS: GH Research (NASDAQ:GHRS) shares closed up 29.83% at $15.80 Numinus Wellness (OTC:NUMIF) shares closed up 16.20% at $0.26 Cybin (AMEX:CYBN) shares closed up 14.94% at $0.71 Compass Pathways (NASDAQ:CMPS) shares closed up 14.69% at $20.07 ATAI Life Sciences (NASDAQ:ATAI) shares closed up 6.57% at $4.38 Revive Therapeutics (OTC:RVVTF) shares closed up 4.63% at $0.36 Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.84% at $1.00 Field Trip Health (NASDAQ:FTRP) shares closed up 1.12% at $0.84 LOSERS: Mind Medicine (NASDAQ:MNMD) shares closed down 12.15% at $0.62 Allied (OTC:ALID) shares closed down 0.00% at $0.52 Biomind Labs (OTC:BMNDF) shares closed down 0.00% at $
FTRP FAQ
5 questionsWhat does Field Trip Health Ltd. do?
Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; and Field Trip Discovery, a drug development division developing the next generation of psychedelic molecules. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.What is the latest news on FTRP?
Quantisnow has not tracked any new filings, ratings or press releases for FTRP in the last 30 days. The most recent wire item was published on January 9, 2023.Where does FTRP stock trade?
Field Trip Health Ltd. (FTRP) is listed on NASDAQ.What are analysts saying about FTRP?
Field Trip Health Ltd. has had 2 recent analyst actions on file. The most recent action was from HC Wainwright & Co.: Buy with a $25.00 price target on 2021-11-22. Recent price targets range from $20.00 to $25.00.How can I track FTRP on Quantisnow?
Quantisnow aggregates Field Trip Health Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow FTRP to receive live email and push alerts on every new disclosure.